Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes

Epithelial-mesenchymal transition (EMT) is a physiological process that has been recognized to occur during the progression of an increasingly large number of human diseases, including liver fibrosis, cirrhosis, and hepatocellular carcinoma. The activation of transforming growth factor β (TGF-β) sig...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awduron:	Yue‐Lei Chen, Jing Lv, Xiaolei Ye, Mingyu Sun, Qin Xu, Chenghai Liu, Lihua Min, Huiping Li, Ping Liu, Xiaoyan Ding
Fformat:	Artigo
Iaith:	Saesneg
Cyhoeddwyd:	2011
Mynediad Ar-lein:	https://doi.org/10.1002/hep.24254 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.24254
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells
gan: Zhang, Juyong, et al.
Cyhoeddwyd: (2013)

Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
gan: Tomoyuki Nagai, et al.
Cyhoeddwyd: (2011)

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
gan: Yanru Deng, et al.
Cyhoeddwyd: (2016)

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
gan: Deng, Yan-Ru, et al.
Cyhoeddwyd: (2016)

The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
gan: Zhang, Kun, et al.
Cyhoeddwyd: (2019)

The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
gan: Kun Zhang, et al.
Cyhoeddwyd: (2019)

Histone deacetylase inhibition suppresses the transforming growth factor β1-induced epithelial-to-mesenchymal transition in hepatocytes
gan: Aki Kaimori, et al.
Cyhoeddwyd: (2010)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
gan: Yi‐Lang Chen, et al.
Cyhoeddwyd: (2013)

Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
gan: Chen, Weibo, et al.
Cyhoeddwyd: (2019)

PDCD2 sensitizes HepG2 cells to sorafenib by suppressing epithelial-mesenchymal transition
gan: Liu, Hongyu, et al.
Cyhoeddwyd: (2019)

Autophagy regulates hepatocyte identity and epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions promoting Snail degradation
gan: Germana Grassi, et al.
Cyhoeddwyd: (2015)

SYNCRIP Modulates the Epithelial-Mesenchymal Transition in Hepatocytes and HCC Cells
gan: Riccioni, Veronica, et al.
Cyhoeddwyd: (2022)

Hypoxia Stimulates Hepatocyte Epithelial to Mesenchymal Transition by Hypoxiainducible Factor- and Transforming Growth Factor-β-dependent Mechanisms
gan: Copple, Bryan L.
Cyhoeddwyd: (2010)

Melatonin Inhibits Transforming Growth Factor-β1-Induced Epithelial–Mesenchymal Transition in AML12 Hepatocytes
gan: Kim, Jung-Yeon, et al.
Cyhoeddwyd: (2019)

Regorafenib reverses <scp>HGF</scp>‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
gan: Weibo Chen, et al.
Cyhoeddwyd: (2018)

Sorafenib Ameliorates Renal Fibrosis through Inhibition of TGF-β-Induced Epithelial-Mesenchymal Transition
gan: Jia, Lining, et al.
Cyhoeddwyd: (2015)

Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
gan: Taura, Kojiro, et al.
Cyhoeddwyd: (2010)

Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice
gan: Kojiro Taura, et al.
Cyhoeddwyd: (2009)

Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-β-dependent mechanisms
gan: Bryan L. Copple
Cyhoeddwyd: (2010)

Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
gan: Chen, Y-L, et al.
Cyhoeddwyd: (2013)

Dual role of RACK1 in airway epithelial mesenchymal transition and apoptosis
gan: Pu, Yue, et al.
Cyhoeddwyd: (2020)

A Novel Mechanism by which Hepatocyte Growth Factor Blocks Tubular Epithelial to Mesenchymal Transition
gan: Junwei Yang, et al.
Cyhoeddwyd: (2004)

Corrigendum to: Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
Cyhoeddwyd: (2022)

FZD5 prevents epithelial-mesenchymal transition in gastric cancer
gan: Dong, Dan, et al.
Cyhoeddwyd: (2021)

MicroRNA-101 inhibits renal tubular epithelial-to-mesenchymal transition by targeting TGF-β1 type I receptor
gan: Wang, Qinglan, et al.
Cyhoeddwyd: (2021)

Sorafenib inhibits ovarian cancer cell proliferation and mobility and induces radiosensitivity by targeting the tumor cell epithelial–mesenchymal transition
gan: Tian, Chuntao, et al.
Cyhoeddwyd: (2022)

Hepatitis C Virus Induces Epithelial-Mesenchymal Transition in Primary Human Hepatocytes
gan: Bose, Sandip K., et al.
Cyhoeddwyd: (2012)

Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition
gan: Michael Zeisberg, et al.
Cyhoeddwyd: (2007)

Hepatitis C Virus Induces Epithelial-Mesenchymal Transition in Primary Human Hepatocytes
gan: Sandip K. Bose, et al.
Cyhoeddwyd: (2012)

Human lens epithelial cell apoptosis and epithelial to mesenchymal transition in femtosecond laser-assisted cataract surgery
gan: Sun, Wei, et al.
Cyhoeddwyd: (2018)

C-phycocyanin inhibits epithelial-to-mesenchymal transition in Caski cells
gan: Ji, Huanhuan, et al.
Cyhoeddwyd: (2020)

KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition
gan: Hu, Bo, et al.
Cyhoeddwyd: (2019)

Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
gan: Liao, Li-Zhu, et al.
Cyhoeddwyd: (2020)

Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells
gan: Xu, Gui-Li, et al.
Cyhoeddwyd: (2020)

Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
gan: Li-Zhu Liao, et al.
Cyhoeddwyd: (2020)

Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells
gan: Padilla-Nash, Hesed M., et al.
Cyhoeddwyd: (2013)

Salvianolic acid B prevents epithelial-to-mesenchymal transition through the TGF-β1 signal transduction pathway in vivo and in vitro
gan: Qinglan Wang, et al.
Cyhoeddwyd: (2010)

ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression
gan: Lahsnig, C, et al.
Cyhoeddwyd: (2008)

Murine Cirrhosis Induces Hepatocyte Epithelial Mesenchymal Transition and Alterations in Survival Signaling Pathways
gan: Nitta, Takashi, et al.
Cyhoeddwyd: (2008)

Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways
gan: Takashi Nitta, et al.
Cyhoeddwyd: (2008)